Data Insights
No filters selected
No filters selected
No filters selected
No filters selected
Taletrectinib adipate by Nuvation Bio for Solid Tumor: Likelihood of Approval
Taletrectinib adipate is under clinical development by Nuvation Bio and currently in Phase I for Solid Tumor. According to GlobalData,...
Taletrectinib adipate by Nuvation Bio for Colorectal Cancer: Likelihood of Approval
Taletrectinib adipate is under clinical development by Nuvation Bio and currently in Phase I for Colorectal Cancer. According to GlobalData,...
Taletrectinib adipate by Nuvation Bio for Non-Small Cell Lung Cancer: Likelihood of Approval
Taletrectinib adipate is under clinical development by Nuvation Bio and currently in Pre-Registration for Non-Small Cell Lung Cancer. According to...